<DOC>
	<DOCNO>NCT00586118</DOCNO>
	<brief_summary>The evaluation present study work practicability inhalative sedation ICU , potential benefit limitation ACD system postoperative sedate patient population comparison standard intravenous sedation regimen propofol , focus renal hepatic function , cardioprotection pharmacoeconomics</brief_summary>
	<brief_title>Inhalative Sedation ICU With Sevoflurane Via Anaesthetic Conserving Device Compared Propofol</brief_title>
	<detailed_description>A goal-oriented sedation complies ability sedate patient deeply necessary , allow modern ventilation regimen early spontaneous breathe pain-free cooperative patient . The ideal sedative agent - short duration action , predictable wake-up time , low drug toxicity , haemodynamic stability less side effect , rational pharmacoeconomic impact nowadays - still find . Inhalative anaesthetic show property , introduction AnaConDaÂ© ( Anesthetic Conserving Device , ACD ) 2005 , use volatile anaesthetic intensive care unit ( ICU ) require specific evaporate device scavenge system . The ACD , modify heat- moisture filter , connect breathe circuit conventional ICU ventilator syringe pump delivers volatile anaesthetic ACD vaporize rod . Most exhaled gas absorb charcoal filter 's membrane reflect patient follow inspiration . Randomised , control comparative study use volatile anaesthetic ICU via innovative device still miss . Isoflurane study small patient population comparison midazolam , Sevoflurane - newer volatile agent short action , brief elimination time , low hepatic biodegradation - study intraoperatively short-term sedation . This first prospective , randomise , clinical study feasibility sevoflurane via ACD sedation ICU patient 72 hour comparison standard intravenous sedation propofol . The investigation work potential benefit limitation use volatile agent ICU , quality sedation ( Richmond Agitation Sedation Scale , BIS ) , infusion rate stability sevoflurane respiratory parameter , short-term recovery ( time discontinuation infusion follow verbal command extubation ) , haemodynamics , renal hepatic function adverse side effect .</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>1880 year elective operative procedure , indication admission ICU postoperative sedation ASA IIII weight 50120 kg Haemoglobin &gt; 10 g/dl ability acceptance agree study participation malignant hyperthermia muscle diseases weakness liver insufficiency ( ASAT , ALAT &gt; 40 U/min ) pancreas insufficiency emergency woman child bear age miss negative pregnancy test , pregnancy lactation diseases central nervous system ( M. Parkinson multiple sclerosis ) increase intracranial pressure , head trauma preexist delirium , agitation psychiatric derangement alcohol drug abuse ( include opioid abuse ) allergy study agent refusal patient participate study participation another study project .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Sedation</keyword>
	<keyword>Volatile anaesthetic</keyword>
	<keyword>Sevoflurane</keyword>
	<keyword>Propofol</keyword>
	<keyword>Recovery</keyword>
</DOC>